After months of international availability, the Dexcom G7 constant glucose monitor received its FDA clearance to distribute in the US. Ahead of the wide rollout, we got to go hands-on with a demo ...
LONDON--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM ...
MUNICH — A novel implanted continuous glucose sensor (Eversense, Senseonics) is safe and accurately reflected blood glucose levels for an average of about 6 months, study results show. Data from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback